Clinical Trial Update: Effects of Dapagliflozin on Progression of Alport Syndrome

View source ↗

Summary

Clinical trial update on the effects of dapagliflozin for progression of Alport syndrome; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Syndrome

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Alport Syndrome | Status: ACTIVE_NOT_RECRUITING